Filing Details

Accession Number:
0000711377-12-000012
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-08-10 13:18:58
Reporting Period:
2012-08-08
Filing Date:
2012-08-10
Accepted Time:
2012-08-10 13:18:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187556 M Lon Bohannon Neogen Corp
620 Lesher Place
Lansing MI 48912
President & Coo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-08-08 1,000 $39.92 307,574 No 4 J Direct
Common Stock Disposition 2012-08-08 7,565 $39.83 300,009 No 4 S Direct
Common Stock Acquisiton 2012-08-09 21,601 $13.55 321,610 No 4 M Direct
Common Stock Disposition 2012-08-09 14,036 $38.82 307,574 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2012-08-09 21,601 $0.00 21,601 $13.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
136,782 2012-08-09 No 4 M Direct
Footnotes
  1. Options were granted 8/9/2007, vested 20% annually for five years, and expire on 8/9/2012
  2. These shares were gifted to various charities by Mr. Bohannon and his wife